Miroslav S. Ravic
Chief Executive Officer at MGB Biopharma Ltd.
Miroslav S. Ravic active positions
Companies | Position | Start | End |
---|---|---|---|
MGB Biopharma Ltd.
MGB Biopharma Ltd. BiotechnologyHealth Technology MGB Biopharma Ltd. develops anti-infective medicines. Its lead candidate, MGB-BP-3, is an antibacterial which is active against important multi-resistant and susceptible Gram-positive pathogens. The firm develops an oral formulation of MGB-BP-3 for the treatment of clostridium difficile associated disease. The company was founded by Miroslav Ravic, Gavin David Clark and Raymond Spencer in 2010 and is headquartered in Glasgow, the United Kingdom. | Director/Board Member | 2011-02-08 | - |
Chief Executive Officer | 2010-04-18 | - | |
Chief Tech/Sci/R&D Officer | 2009-12-31 | - | |
Founder | 2011-02-08 | - | |
British Pharmacological Society
British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Corporate Officer/Principal | 2011-02-09 | - |
The American Society for Clinical Pharmacology & Therapeutics
The American Society for Clinical Pharmacology & Therapeutics Miscellaneous Commercial ServicesCommercial Services The American Society for Clinical Pharmacology & Therapeutics is a scientific and professional organization that serves the disciplines of clinical pharmacology and translational medicine. The non-profit company is based in Alexandria, VA. The CEO of the company is Sharon Swan. | Corporate Officer/Principal | 2011-02-09 | - |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Corporate Officer/Principal | - | - |
Career history of Miroslav S. Ravic
Former positions of Miroslav S. Ravic
Companies | Position | Start | End |
---|---|---|---|
LipoNova AG
LipoNova AG Medical/Nursing ServicesHealth Services The Company's principal activity is drug development. The Company is developer of effective therapies for diseases such as non-metastatic renal cell carcinoma (RCC). The Company also develops autologous tumour vaccines. | Director/Board Member | - | - |
President | 2005-12-31 | 2006-12-31 | |
Antisoma Research Ltd. | President | - | 2004-12-31 |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Corporate Officer/Principal | - | - |
EISAI CO., LTD. | Corporate Officer/Principal | - | - |
Affimed NV Niederlassung Deutschland
Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Chief Tech/Sci/R&D Officer | 2005-12-31 | - |
░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Training of Miroslav S. Ravic
University of London | Doctorate Degree |
University of Belgrade | Doctorate Degree |
Statistics
International
United Kingdom | 7 |
United States | 4 |
Germany | 4 |
Operational
Corporate Officer/Principal | 7 |
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 3 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Health Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
PHARMSYNTHEZ | Health Technology |
EISAI CO., LTD. | Health Technology |
Private companies | 11 |
---|---|
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Finance |
MGB Biopharma Ltd.
MGB Biopharma Ltd. BiotechnologyHealth Technology MGB Biopharma Ltd. develops anti-infective medicines. Its lead candidate, MGB-BP-3, is an antibacterial which is active against important multi-resistant and susceptible Gram-positive pathogens. The firm develops an oral formulation of MGB-BP-3 for the treatment of clostridium difficile associated disease. The company was founded by Miroslav Ravic, Gavin David Clark and Raymond Spencer in 2010 and is headquartered in Glasgow, the United Kingdom. | Health Technology |
Pharmaca Integrative Pharmacy, Inc.
Pharmaca Integrative Pharmacy, Inc. Drugstore ChainsRetail Trade Pharmaca Integrative Pharmacy, Inc. operates as a pharmacy and health store. Its products includes facial care and makeup products, as well as beauty accessories; body care, hair care, bath and shower, sun care and bug spray, shaving and hair removal, hand and foot care, and kids and baby skin care and bath products; vitamins, supplements, minerals, sports and nutrition. The firm has offices in California, New Mexico, Oregon, and Washington. The company was founded by Don L. Summerfield, Dale Schwartz and Barry Perzow in June 2000 and is headquartered in Boulder, CO. | Retail Trade |
LipoNova AG
LipoNova AG Medical/Nursing ServicesHealth Services The Company's principal activity is drug development. The Company is developer of effective therapies for diseases such as non-metastatic renal cell carcinoma (RCC). The Company also develops autologous tumour vaccines. | Health Services |
Pharma Integra Ltd.
Pharma Integra Ltd. Miscellaneous Commercial ServicesCommercial Services Pharma Integra Ltd. engages in scientific and technical activities. The company was founded on October 1, 1998 and is headquartered in London, the United Kingdom. | Commercial Services |
Antisoma Research Ltd. | |
British Pharmacological Society
British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Miscellaneous |
The American Society for Clinical Pharmacology & Therapeutics
The American Society for Clinical Pharmacology & Therapeutics Miscellaneous Commercial ServicesCommercial Services The American Society for Clinical Pharmacology & Therapeutics is a scientific and professional organization that serves the disciplines of clinical pharmacology and translational medicine. The non-profit company is based in Alexandria, VA. The CEO of the company is Sharon Swan. | Commercial Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
Affimed NV Niederlassung Deutschland
Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Health Technology |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
- Stock Market
- Insiders
- Miroslav S. Ravic
- Experience